These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Zakir F; Vaidya B; Goyal AK; Malik B; Vyas SP Drug Deliv; 2010 May; 17(4):238-48. PubMed ID: 20235758 [TBL] [Abstract][Full Text] [Related]
4. Topical delivery of fluconazole: in vitro skin penetration and permeation using emulsions as dosage forms. Ayub AC; Gomes AD; Lima MV; Vianna-Soares CD; Ferreira LA Drug Dev Ind Pharm; 2007 Mar; 33(3):273-80. PubMed ID: 17454060 [TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of lecithin organogel for topical delivery of fluconazole. Jadhav KR; Kadam VJ; Pisal SS Curr Drug Deliv; 2009 Apr; 6(2):174-83. PubMed ID: 19450224 [TBL] [Abstract][Full Text] [Related]
6. Oil-in-water lecithin-based microemulsions as a potential delivery system for amphotericin B. Pestana KC; Formariz TP; Franzini CM; Sarmento VH; Chiavacci LA; Scarpa MV; Egito ES; Oliveira AG Colloids Surf B Biointerfaces; 2008 Oct; 66(2):253-9. PubMed ID: 18676122 [TBL] [Abstract][Full Text] [Related]
7. Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Changez M; Chander J; Dinda AK Colloids Surf B Biointerfaces; 2006 Mar; 48(1):58-66. PubMed ID: 16497490 [TBL] [Abstract][Full Text] [Related]
8. Microemulsion-based hydrogel formulation of ibuprofen for topical delivery. Chen H; Chang X; Du D; Li J; Xu H; Yang X Int J Pharm; 2006 Jun; 315(1-2):52-8. PubMed ID: 16600540 [TBL] [Abstract][Full Text] [Related]
9. Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. Changez M; Varshney M; Chander J; Dinda AK Colloids Surf B Biointerfaces; 2006 Jun; 50(1):18-25. PubMed ID: 16690263 [TBL] [Abstract][Full Text] [Related]
10. Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole. Patel MR; Patel RB; Parikh JR; Solanki AB; Patel BG AAPS PharmSciTech; 2009; 10(3):917-23. PubMed ID: 19609836 [TBL] [Abstract][Full Text] [Related]
11. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. Salerno C; Carlucci AM; Bregni C AAPS PharmSciTech; 2010 Jun; 11(2):986-93. PubMed ID: 20521179 [TBL] [Abstract][Full Text] [Related]
12. Improved efficacy of fluconazole against candidiasis using bio-based microemulsion technique. Nirmala MJ; Mukherjee A; Chandrasekaran N Biotechnol Appl Biochem; 2013; 60(4):417-29. PubMed ID: 23586695 [TBL] [Abstract][Full Text] [Related]
13. Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Verma S; Bhardwaj A; Vij M; Bajpai P; Goutam N; Kumar L Artif Cells Nanomed Biotechnol; 2014 Apr; 42(2):95-101. PubMed ID: 23656670 [TBL] [Abstract][Full Text] [Related]
14. Effect of surfactant concentration on transdermal lidocaine delivery with linker microemulsions. Yuan JS; Yip A; Nguyen N; Chu J; Wen XY; Acosta EJ Int J Pharm; 2010 Jun; 392(1-2):274-84. PubMed ID: 20363304 [TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole. Coneac G; Vlaia V; Olariu I; Muţ AM; Anghel DF; Ilie C; Popoiu C; Lupuleasa D; Vlaia L AAPS PharmSciTech; 2015 Aug; 16(4):889-904. PubMed ID: 25591952 [TBL] [Abstract][Full Text] [Related]
17. Microemulsions as a surrogate carrier for dermal drug delivery. Azeem A; Khan ZI; Aqil M; Ahmad FJ; Khar RK; Talegaonkar S Drug Dev Ind Pharm; 2009 May; 35(5):525-47. PubMed ID: 19016057 [TBL] [Abstract][Full Text] [Related]
18. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Mura S; Manconi M; Sinico C; Valenti D; Fadda AM Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377 [TBL] [Abstract][Full Text] [Related]
19. Extended release of lidocaine from linker-based lecithin microemulsions. Yuan JS; Acosta EJ Int J Pharm; 2009 Feb; 368(1-2):63-71. PubMed ID: 19010404 [TBL] [Abstract][Full Text] [Related]
20. Decrease of liposomal size and retarding effect on fluconazole skin permeation by lysine derivatives. Schwarz JC; Kählig H; Matsko NB; Kratzel M; Husa M; Valenta C J Pharm Sci; 2011 Jul; 100(7):2911-9. PubMed ID: 21319163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]